Etiologic agents and risk factors in nosocomial urinary tract infections;Nozokomiyal üriner sistem enfeksiyonlarιnda etiyolojik etkenler ve risk faktörleri

Mikrobiyoloji Bulteni

Volumn 42, Issue 2, 2008, Pages 245-254

  Akkoyun, Sevinç ^a   Kuloǧlu, Figen ^a   Tokuç, Burcu ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Nosocomial infection; Risk factors; Urinary catheter; Urinary tract infection

Indexed keywords

ACINETOBACTER; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BLADDER CATHETERIZATION; CANDIDA; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA PNEUMONIAE; MALE; MICROBIOLOGY; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; RISK FACTOR; URINARY TRACT INFECTION;

ACINETOBACTER; AGED; CANDIDA; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HUMANS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; RISK FACTORS; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

EID: 52349095912     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Yüce A. Hastane enfeksiyonlarinin önemi, s: 3-5. Yüce A, Çakir N (ed), Hastane Infeksiyonlari. 2003, 1.baski. Güven Kitabevi, Izmir.
2. Edmond MB, Wenzel RP. Organization for infection control, pp: 2988-91. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of Infectious Diseases. 2000, 5th ed. Churchill Livingstone, Philadelphia.
3. Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1997; 11: 609-22.
4. Wagenlehner FM, Naber KG. Hospital-acquired urinary tract infections. J Hosp Infect 2000; 46: 171-81.
5. Bakir M. Nozokomiyal üriner sistem enfeksiyonlari, s: 531-55. Doǧanay M, Ünal S (ed), Hastane Infeksiyonlari. 2003, Bilimsel Tip Kitabevi, Ankara.
6. Burke JP, Zavasky DM. Nosocomial urinary tract infections, pp: 173-87. In: Mayhall CG (ed), Hospital Epidemiology and Infection Control. 1999, 2nd ed. Lippincott Williams and Wilkins, Philadelphia.
7. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, pp: 1-20. In: Olmstred RN (ed), APIC Infection Control and Applied Epidemiology: Principles and Practice. 1996. Mosby Co., St Louis.
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved Standard. 2003, 8th ed. NCCLS Document M2-A8. NCCLS/CLSI, Wayne, PA.
9. Gülay Z. ESBL'/erin tani yöntemleri, s: 13-25. Köksal I (ed), Yeni ve Yeniden Gündeme Gelen Infeksiyonlar: Genişlemiş Spektrumlu Beta-laktamazlar (ESBL). 2004. Bilimsel Tip Yayinevi, Ankara.
10. Bouza E, San Juan R, Munoz P, Voss A and European Study Group on Nosocomial Infections. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). Clin Microbiol Infect 2001; 7:532-42.
11. Greenberg RS, Daniels SR, Flanders WD, Eley JW, Boring JR. Cumulative incidence or incidence proportion ratio, pp: 16-8. In: Medical Epidemiology. 2001, 31d ed. McGraw-Hill Co., USA.
12. Akata F, Otkun M, Kuloǧlu F, Erkan T, Keskin S, Tuǧrul M. Trakya Üniversitesi Tip Fakültesi Hastanesi'nde nozokomiyal enfeksiyon oranlarinin deǧerlendirilmesi. Hastane Infeksiyonlari Derg 2006; 10 (Ek 1): 38.
13. Leblebicioǧlu H, Esen S. Hospital-acquired urinary tract infections in Turkey: a nationwide multicenter point prevalence study. J Hosp Infect 2003; 53: 207-10.
14. Bakir M, Elaldi N, Dökmentaş I, Bilgiç A, Bakici Z, Şahin F. Nozokomiyal üriner sistem enfeksiyonlari: insidans, etyoloji ve sonuçlar. Hastane Infeksiyonlari Derg 2003; 7: 35-44.
15. Lundstrom T, Sobel J. Nosocomial candiduria: a review. Clin Infect Dis 2001; 32: 1602-7.
16. Febre N, Silva V, Medeiros EAS, Wey SB, Colombo AL, Fischman O. Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catheterization. J Clin Microbiol 1999; 37: 1584-6.
17. Gür D. Beta-laktamazlar. Flora 1997; 3 (Ek 1): 1-16.
18. Aydemir A, Yalçi A, Pişkin N, Gürbüz Y, Türkyilmaz R. E.coli ve K.pneumoniae suşlarinin genişlemiş spektrumlu beta-laktamaz üretme ve antibiyotik direnç oranlari. Klimik Derg 2006; 19: 63-8.
19. Paterson DL, Ko WC, Gottberg AV, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004; 140: 26-32.
20. Alcantar-Curiel D, Tinoco JC, Gayosso C, et al. Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes. Clin Infect Dis 2004; 38: 1067-74.
21. Bhavnani SM, Ambrose PG, Craig WA, Dudley MN, Jones RN. Outcomes evaluation of patients with ESBL and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 2006; 54: 231-6.
22. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriacea. Am J Infect Control 2006; 34: S20-8.